Skip to content
★ Sign in to follow
AL

Arvee Laboratories (India) Limited Stock: price and insider trades · India

IN·Mcap ₹1.7BHealth Care

No insider purchase over the last 90 days. The latest, by MITABEN BHARATBHAI CHOKSHI, was filed 27 Dec 2022.

Arvee Laboratories (India) Limited: what insiders have been doing

Arvee Laboratories (India) Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). Nothing new has been filed by managers of Arvee Laboratories (India) Limited in twelve months, the latest record being from 27 December 2022.

For comparison within the same sector, see the insider buying recorded at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.

Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
4 ops. · all time
Sell Volume
n/a
4 ops. · all time
Fundamental score
Ranked 13,773 of 26,911 companies
50.8
score / 100
Value
36
Quality
66
FCF yld-1.3%
Earn yld1.1%
EV/EBITDA·
ROE7.8%
Gross mgn40%
Net mgn8.0%
Debt/EBITDA0.3x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended March 2025 · cache

₹156.72
Analyst consensus
·
Income statement
Revenue₹384.4M
Gross profit₹135.1M35% margin
EBITDA₹41.7M11% margin
Net income₹21.5M8.0% margin
Valuation
PER (trailing)83.4x
P/Book5.1x
Beta0.51
Balance sheet & cash
Market cap₹1.7B
Total debt₹10.3M
Free Cash Flow-₹20.6M
Debt / Equity3%
Profitability & ownership
ROE7.8%
ROA3.1%
Last declaration on 27 December 2022
Declarations8 total
  • ▲
    Executives
    0SEBI
    669,000 sharesEquity SharesSEBI:76df99221cb92c30b5e24ea7b59bdb1f7e849da9
    Canonical exit: 27 Mar 2023 (T+90)
  • ▼
    Executives
    0SEBI
    669,000 sharesEquity SharesSEBI:022abcb29341bef38a41e1d4e81ff69f1ae2f55a
  • ▼
    Executives
    0SEBI
    669,000 sharesEquity SharesSEBI:6621d6601beda31346775baf208d33067a9f42a0
  • ▲
    Executives
    0SEBI
    2,039,000 sharesEquity SharesSEBI:fc9ebf59e282f07396ec2f942d5798f26377f1fc
    Canonical exit: 13 Dec 2022 (T+90)
  • ▲
    Executives
    0SEBI
    1,337,000 sharesEquity SharesSEBI:1bd8642c0b2a0ad6ddb8a93d4105ae6b2d6fd60f
    Canonical exit: 13 Dec 2022 (T+90)
  • ▼
    Executives
    0SEBI
    1,370,000 sharesEquity SharesSEBI:fcc5a82680678932988aa096a4ca53fe63548395
  • ▼
    Executives
    0SEBI
    1,337,000 sharesEquity SharesSEBI:6bf44f6249e6aae776bc91ee4d1cdb2a9d4f0170
  • ▲
    Executives
    0SEBI
    662,000 sharesEquity SharesSEBI:40722cc0976b78eb4882fec53ab411f8b1d5faa9
    Canonical exit: 4 May 2022 (T+90)

8 of 8 declarations

About Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited is a company engaged in the manufacturing of pharmaceutical and healthcare products. It operates on the Bombay Stock Exchange.